Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/740260/000074026017000056/vtr-20161231x10k.htm
May 2022
May 2022
March 2022
February 2022
January 2022
January 2022
November 2021
November 2021
September 2021
August 2021
Exhibit 99.1
Ventas Reports 2016 Fourth Quarter and Full-Year Results
CHICAGO--(BUSINESS WIRE)--February 10, 2017--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced earnings for the fourth quarter and full year ended December 31, 2016, driven by the Company’s high-quality healthcare, senior living and life science properties and accretive investments:
Track Record of Excellence Continued
“Ventas extended its long track record of excellence and success in 2016, generating strong growth and income from a high-quality diverse portfolio while enhancing its financial strength,” said Chairman and Chief Executive Officer Debra A. Cafaro. “We also delivered 16 percent total shareholder return as our exciting investment in life science and innovation centers and strategic dispositions created additional value. We are confident that demand from an aging population combined with our productive and cohesive team, our leading operator partners and our attractive mix of healthcare, senior living and life science properties will sustain excellence over the long term.
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/740260/000074026017000056/vtr-20161231x10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Ventas Inc.
Ventas Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
Rating
Learn More![]()
The $78.3 million decrease in merger-related expenses and deal costs in 2016 over the prior year is primarily due to the January 2015 HCT acquisition and the August 2015 acquisition of Ardent Health Services, Inc., partially offset by costs incurred relating to the September 2016 Life Sciences Acquisition.
Pursuant to the terms of certain leases with one of our tenants, if interest rates increase on certain variable rate debt that we have totaling $80.0 million as of December 31, 2016, our tenant is required to pay us additional rent on a dollar-for-dollar basis in an amount equal to the increase in interest expense resulting from the increased interest rates.
This includes determining the value of the buildings, land and improvements, construction in progress, ground leases, tenant improvements, in-place leases, above andor below market leases, purchase option intangible assets andor liabilities, and any debt assumed.
In addition, any failure, inability or unwillingness by Brookdale Senior Living, Kindred or Ardent to effectively conduct its operations or to maintain and improve our properties could adversely affect its business reputation and its ability to attract and retain patients and residents in our properties, which could have an indirect Material Adverse Effect on us.
Includes $371.2 million of borrowings under our unsecured term loan due 2019, $600.0 million outstanding principal amount of our 4.00% senior notes due 2019, $297.8 million outstanding principal amount of our 3.00% senior notes, series A due 2019, $500.0 million outstanding principal amount of our 2.700% senior notes due 2020 and $900.0 million of borrowings under our unsecured term loan due 2020.
However, from time to time,...Read more
We aim to enhance shareholder...Read more
Assetliability management, a key element...Read more
On the issuance date, we...Read more
On the issuance date, we...Read more
Cash used in investing activities...Read more
The increase in our office...Read more
In 2015, the FASB provided...Read more
Described below are the non-GAAP...Read more
See Risk Factors Risks Arising...Read more
We define Adjusted EBITDA as...Read more
Property-level operating expenses also increased...Read more
Includes $146.5 million of borrowings...Read more
You should not consider these...Read more
The increase in our office...Read more
The $59.6 million increase in...Read more
This difference is primarily due...Read more
As of December 31, 2016,...Read more
financial condition and results of...Read more
We evaluate performance of the...Read more
However, since real estate values...Read more
We apply the effective interest...Read more
We recognize the increased rental...Read more
During 2016, our principal sources...Read more
Effective management of these risks...Read more
See Risk Factors Risks Arising...Read more
Cash flows from operating activities...Read more
The $49.0 million increase in...Read more
We calculate the fair value...Read more
Our senior living operations segment...Read more
However, for certain acquired properties...Read more
We assess assumed operating leases,...Read more
We define normalized FFO as...Read more
If interest rates have risen...Read more
In addition, from time to...Read more
For the year ended December...Read more
If our evaluation of these...Read more
Consolidated Statements of Income d...Read more
The $79.6 million increase in...Read more
See Risk Factors Risks Arising...Read more
The TRS losses were mainly...Read more
The TRS losses were mainly...Read more
See Risk Factors Risks Arising...Read more
We do not amortize the...Read more
Our effective interest rate was...Read more
Our effective interest rate was...Read more
However, an inability to access...Read more
Therefore, the increase in interest...Read more
A VIE is broadly defined...Read more
The following table sets forth...Read more
However, from time to time,...Read more
Our normalized FFO for the...Read more
The redemption was funded using...Read more
The DRIP was suspended effective...Read more
ASU 2016-02 is not effective...Read more
In January and February 2017,...Read more
We include all lease-related intangible...Read more
In January and February 2017,...Read more
In December 2016, our fourth...Read more
We account for acquisitions using...Read more
The $7.8 million decrease in...Read more
Conversely, lower interest rates at...Read more
We consider Adjusted EBITDA an...Read more
We determine the fair value...Read more
We recognize interest income from...Read more
NOI for our triple-net leased...Read more
Using this information, we calculate...Read more
Depreciation and amortization expense increased...Read more
Management fee revenue also increased...Read more
Aggregate net proceeds for these...Read more
We identify the primary beneficiary...Read more
In order to continue to...Read more
As a result of our...Read more
Through our Lillibridge Healthcare Services,...Read more
To the extent the lease...Read more
We adjust the net book...Read more
Under ASU 2016-13, an entity...Read more
The following discussion addresses our...Read more
As of December 31, 2016,...Read more
Although we have various rights...Read more
In May 2015, we repaid...Read more
As of December 31, 2016,...Read more
However, if our judgment or...Read more
Some of our triple-net lease...Read more
We recognize interest and penalties,...Read more
Merger-related expenses and deal costs...Read more
Merger-related expenses and deal costs...Read more
We are exposed to market...Read more
For that reason, we consider...Read more
Impairment of Long-Lived and Intangible...Read more
As of December 31, 2016,...Read more
Separately, in October 2016, we...Read more
Gain on real estate dispositions...Read more
Gain on real estate dispositions...Read more
Gain loss on real estate...Read more
Gain on real estate dispositions...Read more
Gain on non-real estate dispositions...Read more
Gain on real estate dispositions...Read more
Gain on real estate dispositions...Read more
We recognized a gain on...Read more
Gain on real estate dispositions...Read more
Gain on real estate dispositions...Read more
Gain on real estate dispositions...Read more
Gain on Real Estate Dispositions...Read more
Under certain circumstances, contractual and...Read more
Recognizing rental income on a...Read more
We may change our original...Read more
GAAP requires us to make...Read more
We estimate the fair value...Read more
In September 2016, we modified...Read more
Our ability to access capital...Read more
We expect that these liquidity...Read more
The non-GAAP financial measures we...Read more
NAREIT defines FFO as net...Read more
In May 2016, we repaid...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Ventas Inc provided additional information to their SEC Filing as exhibits
Ticker: VTR
CIK: 740260
Form Type: 10-K Annual Report
Accession Number: 0000740260-17-000056
Submitted to the SEC: Mon Feb 13 2017 9:18:07 PM EST
Accepted by the SEC: Tue Feb 14 2017
Period: Saturday, December 31, 2016
Industry: Real Estate Investment Trusts